Muireann Bolger

Key details

Muireann Bolger is deputy editor of World Intellectual Property Review and Life Sciences Intellectual Property Review in London, where she covers trademarks, brands, as well as wider developments across the intellectual property sector.

She regularly attends and covers major IP conferences around the world, reporting on the latest legal, commercial and policy developments and interviewing leading figures from across the sector. She has also co-authored industry reports with leading IP organisations, including the International Trademark Association (INTA).

She is the editor of the website’s Community & Inclusion channel and the annual Influential Women in IP list, which celebrates the achievements and contributions of leading women across the IP sector.

Originally from Ireland, Muireann has nearly two decades of experience reporting on brand developments, strategy, and wider business issues.

In her current role, she writes and edits news and analysis for an international audience of IP professionals, while also championing inclusion within the profession.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 415

Articles by Muireann Bolger

California firm entices quartet of litigators from rival
Americas
Life sciences practice boosted by four-partner ‘powerhouse’ team | Attorneys have all achieved notable trial outcomes for pharma companies.   17 November 2022
Patent firms unveil joint UPC ‘powerhouse’
Pharma
Firms aim to form a UPC litigation alliance | New court has significant implications for life sciences | UPC faces calls for delay over concerns regarding its case management system.   15 November 2022
Sea change: a Q&A with Kathi Vidal
article
WIPR Diversity sat down with Kathi Vidal, director of the US Patent and Trademark Office, to talk about her bold plans to encourage more women into the field of patents, expand the bar and make the agency a great place to work.   8 November 2022
Americas
Lawsuit centred on methods for stapling tissue during surgery | Delaware federal jury found in favour of Rex Medical.   20 October 2022
Pharma
Nexus raises second complaint against same parties in a month | Ready-to-use drug that can raise the blood pressure of hypotension patients at issue.   13 October 2022
Americas
Dispute against LabCorp claims wilful infringement | Plaintiff has also sued Illumina, Roche and Myriad in separate cases.   6 October 2022
article
Antiviral treatment could potentially be distributed across 117 countries | MPP looks for interest from potential sublicensees   4 October 2022
article
Bristows has announced that competition law expert Stephen Smith will be the new joint managing partner of the firm   4 October 2022
Pharma
MSD, known as Merck in the US and Canada, has won against a case concerning branded diabetes treatment Janumet XR at the US Court of Appeals for the Federal Circuit.   29 September 2022
article
Law firm Finnegan has announced that partner Scott Burwell has been appointed as the firm’s partner-in-charge of diversity, equity, and inclusion.   27 September 2022

Not finding what you're looking for, please try resetting your applied search and filters,
or try the
full site search.